Medical

• New Imaging  - A medical device company that is developing innovative solutions to assist physicians in preventing and reducing neurological damage that frequently occurs during traumatic brain injury, stroke, or  vasospasms. The Company has developed a proprietary technology, with which physicians can manage patients` therapy significantly more efficiently and more cost effectively. The company provides practitioners the ability, for the first time, to measure blood oxygen levels within specific areas of the body on a non-invasive, quantifiable basis. . The  technology offers substantial benefits over current solutions, including higher accuracy, a universal level of measurement, and ease of use.

•  Imaging, -  Gradient Coils - The company is designing a advanced Gradient Coils for the MRI market. The first product is planed to be the 3D Gradient Coil, based on proprietary algorithm of the company.

• Drug Discovery - A breakthrough Drug discovery company is completing a private financing round. The company development-stage biopharmaceutical company engaged in the discovery and development of therapeutic polypeptides. The development is based on a core, next generation, proprietary combinatorial biology, high throughput screening platform technology. The company demonstrated these days its ability with first commercial contracts.

• Stents – The company develops the next generation of Stents, enables simpler, safer, less side effects procedures. Treatments will be shorter and more efficient. The solution well suitable for Acute MI (heart attack) and carotid (stroke) treatments, creating an opportunity to expand.

• Embolic Stroke  - The company developed portfolio of technologies and methods for prevention of embolic stroke and for treatment of intracranial aneurysms.. The company has developed an intracranial aneurysm occluder. The basic research including the efficacy of this device for prevention and treatment of hemorrhagic stroke is successfully being completed. The company has (1) completed a fully functioning prototype, (2) successfully proven its new concept both in vitro and in vivo.

Semiconducter 

• Semiconductor - Presents the global semiconductor industry with a new roadmap to guide a third breakthrough generation in solid-state electronics. With offices in Israel and Switzerland, the company harnesses the considerable intellectual powers of leading scientists from the Weizmann Institute of Science in Israel and a high caliber team of researchers and technologists from around the world. Its mission: developing a new transistor that will fundamentally affect the entire industry and lead it confidently towards new-century applications based on its technology.

Funds Funding

We are seeking funding for two veteran well reputed Israeli funds - one is very early stage and the other is later stage international fund.